State MI
Clinical Trials in Michigan
Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.
Top Conditions in Michigan
NCT06465745 N/A
Recruiting
AltaValve Pivotal Trial
Condition
Mitral Regurgitation
Enrollment
450 pts
Location
United States, Germany, Greece
Sponsor
4C Medical Technologies, Inc.
NCT05605899 Phase 3
Recruiting
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-...
Condition
High-risk Large B-cell Lymphoma (LBCL)
Enrollment
300 pts
Location
United States, Australia, Austria
Sponsor
Kite, A Gilead Company
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT05330221 N/A
Recruiting
Project 2: ACHIEVE- HF
Condition
Heart Failure
Enrollment
364 pts
Location
United States
Sponsor
Henry Ford Health System
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT05595460 Phase 1
Recruiting
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Condition
SCLC,Extensive Stage
Enrollment
49 pts
Location
United States, Puerto Rico
Sponsor
RayzeBio, Inc.
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06269705 Phase 3
Recruiting
ZILRETTA in Subjects With Shoulder Osteoarthritis
Condition
Glenohumeral Osteoarthritis
Enrollment
150 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
NCT05999994 Phase 2
Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for ...
Condition
Neoplasms
Enrollment
105 pts
Location
United States, Australia, Belgium
Sponsor
Eli Lilly and Company
NCT04998669 Phase 2
Recruiting
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed o...
Condition
Follicular Lymphoma
Enrollment
100 pts
Location
United States
Sponsor
Juan P. Alderuccio, MD
NCT07046260 N/A
Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
Condition
Cancer
Enrollment
1,650 pts
Location
United States
Sponsor
Harbinger Health
NCT06462183 Phase 1
Recruiting
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Ade...
Condition
Adenoid Cystic Carcinoma
Enrollment
105 pts
Location
United States, Canada
Sponsor
Rgenta Therapeutics Inc
NCT04777994 Phase 1
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumo...
Condition
Advanced Solid Tumor Cancer
Enrollment
248 pts
Location
United States, France, Israel
Sponsor
Calico Life Sciences LLC
NCT06339827 N/A
Recruiting
ASk Questions in GYnecologic Oncology (ASQ-GYO)
Condition
Ovarian Cancer
Enrollment
70 pts
Location
United States
Sponsor
Ira Winer
NCT04705766 N/A
Recruiting
KIDney Injury in Times of COVID-19 (KIDCOV)
Condition
SARS-CoV Infection
Enrollment
2,000 pts
Location
United States
Sponsor
University of California, San
NCT05051722 N/A
Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer,...
Condition
Endometrial Cancer
Enrollment
3,110 pts
Location
United States
Sponsor
Mayo Clinic
NCT04031677 Phase 3
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sa...
Condition
Retroperitoneal Sarcoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
European Organisation for Rese
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06701656 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevac...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT07150845 Phase 2
Recruiting
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
Condition
Atoptic Dermatitis
Enrollment
120 pts
Location
United States, New Zealand
Sponsor
Evommune, Inc.
NCT06075745 Phase 2
Recruiting
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Condition
Liver Transplant
Enrollment
416 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05182372 N/A
Recruiting
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities
Condition
Insomnia
Enrollment
600 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06445972 Phase 1, Phase 2
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenoca...
Condition
Gastroesophageal Junction
Enrollment
210 pts
Location
United States, Brazil, Chile
Sponsor
Merck Sharp & Dohme LLC